CRON — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-05-11

• •expectations related to markets outside of Canada and Israel, and our ability to successfully distribute the PEACE NATURALS® brand in those markets;

• •expectations related to our agreement to acquire CanAdelaar B.V. (“CanAdelaar”), including the timing and completion of the transaction, and the anticipated costs, benefits and integration matters associated therewith and the performance of the business from and following closing;

• •expectations related to the impact of the renewed share repurchase program that was authorized on May 8, 2026, including the timing and amount of repurchases;

• all); difficulty raising capital; the potential adverse effects of judicial, regulatory or other proceedings, or threatened litigation or proceedings, on our business, financial condition, results of operations and cash flows; volatility in and/or degradation of general economic, market, industry or…

• In Israel, the Company operates under the Good Agricultural Practices (“IMC-GAP”), Good Manufacturing Practices (“IMC-GMP”) and Good Distribution Practices (“IMC-GDP”) certifications required for the cultivation, production, distribution and marketing of medical cannabis products in Israel.

Text removed vs the prior filing · source: 10-Q · 2025-11-06

• •expectations related to the German, Australian, United Kingdom (“UK”), Swiss, and Malta markets and our ability to successfully distribute the PEACE NATURALS® brand in our overseas markets;

• •expectations related to our announcement of cost-cutting measures, including our decision to wind down operations at our Winnipeg, Manitoba facility (the “Cronos Fermentation Facility”) the expected costs and benefits from the wind-down of production activities, and the pending the sale of the Cron…

• under Part I, Item 1A “Risk Factors” in our Annual Report and under Part II, Item 1A “Risk Factors” in this Quarterly Report. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on Forward-Looking Statements.

• The Cronos GrowCo expansion is now complete and sales from the expansion commenced in Fall 2025. The Company believes this additional supply will fuel growth internationally and within the domestic Canadian market and the wholesale market in 2026. As with any cultivation expansion, it typically take…

• Three months ended September 30,Nine months ended September 30,

Text added vs the prior filing · source: 10-Q · 2026-05-11

• During the three months ended March 31, 2026, the Company had foreign currency loss on translation of $17.9 million. During the three months ended March 31, 2025, the Company had foreign currency loss on translation of $3.1 million.

Text removed vs the prior filing · source: 10-Q · 2025-11-06

• During the three and nine months ended September 30, 2025, the Company had foreign currency gain (loss) on translation of $(26.0) million and $31.1 million, respectively. During the three and nine months ended September 30, 2024 the Company had foreign currency gain (loss) on translation of $12.4 mi…